The regulation of apoptotic cell death

Brazilian Journal of Medical and Biological Research

Volumn 32, Issue 9, 1999, Pages 1053-1061

  Amarante Mendes, G P ^a   Green, D R ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Apoptosis; Bcl 2; Caspase; Cell death; Mitochondria; Oncogene

Indexed keywords

CASPASE;

APOPTOSIS; CELL DEATH; MITOCHONDRION; PHYSIOLOGY; PROTO ONCOGENE; REVIEW;

APOPTOSIS; CASPASES; CELL DEATH; GENES, BCL-2; MITOCHONDRIA;

EID: 0033192654     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1999000900001     Document Type: Article

References (54)

1. Kerr JFR, Wyllie AH & Currie AR (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. British Journal of Cancer, 26: 239-257.
2. Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL & Gregory CD (1998). Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature, 392: 505-509.
3. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR & Girkontaite I (1997). Immunosuppressive effects of apoptotic cells. Nature, 390: 350-351.
4. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY & Henson PM (1998). Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/ paracrine mechanisms involving TGF-beta, PGE2, and PAF. Journal of Clinical Investigation, 101: 890-898.
5. Ren Y, Silverstein RL, Allen J & Savill J (1995). CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. Journal of Experimental Medicine, 181: 1857-1862.
6. Savill JS, Dransfield I, Hogg N & Haslett C (1990). Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature, 343: 170-173.
7. Savill JS, Hogg N, Ren Y & Haslett C (1992). Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. Journal of Clinical Investigation, 90: 1513-1518.
8. Fadok VA, Bratton DL, Frasch SC, Warner ML & Henson PM (1998). The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death and Differentiation, 5: 551-562.
9. Platt N, da Silva RP & Gordon S (1998). Recognizing death: the phagocytosis of apoptotic cells. Trends in Cell Biology, 8: 365-372.
10. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL & Henson PM (1992). Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. Journal of Immunology, 148: 2207-2216.
11. Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader J, van Schie RCAA, LaFace DM & Green DR (1995). Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. Journal of Experimental Medicine, 182: 1-12.
12. Martin SJ, Finucane DM, Amarante-Mendes GP, O'Brien GA & Green DR (1996). Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. Journal of Biological Chemistry, 271: 28753-28756.
13. Thornberry NA (1998). Caspases: key mediators of apoptosis. Chemistry and Biology, 5: R97-R103.
14. Thornberry NA & Lazebnik Y (1998). Caspases: enemies within. Science, 281: 1312-1316.
15. Rotonda J, Nicholson DW, Fazil KM, Gallant M, Gareau Y, Labelle M, Peterson EP, Rasper DM, Ruel R, Vaillancourt JP, Thornberry NA & Becker JW (1996). The three-dimensional structure of apopain/ CPP32, a key mediator of apoptosis. Nature Structural Biology, 3: 619-625.
16. Walker NP, Talanian RV, Brady KD, Dang LC, Bump NJ, Ferenz CR, Franklin S, Ghayur T, Hackett MC, Hammill LD, Herzog L, Hugunin M, Houy W, Mankovich JA, McGuiness L, Orlewicz E, Paskind M, Pratt CA, Reis P, Summani A, Terranova M, Welch JP, Xiong L, Möller A, Tracey DE, Kamen R & Wong WW (1994). Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20/p10)2 homodimer. Cell, 78: 343-352.
17. Wilson KP, Black JA, Thomson JA, Kim EE, Griffith JP, Navia MA, Murcko MA, Chambers SP, Aldape RA, Raybuck SA & Livingston DJ (1994). Structure and mechanism of interleukin-1 beta converting enzyme. Nature, 370: 270-275.
18. Dinarello CA (1998). Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Annals of the New York Academy of Sciences, 856: 1-11.
19. Fantuzzi G, Puren AJ, Harding MW, Livingston DJ & Dinarello CA (1998). Interleukin-18 regulation of interferon gamma production and cell proliferation as shown in interleukin-1beta-converting enzyme (caspase-1)-deficient mice. Blood, 91: 2118-2125.
20. Kim YM, Talanian RV, Li J & Billiar TR (1998). Nitric oxide prevents IL-1beta and IFN-gamma-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1beta-converting enzyme). Journal of Immunology, 161: 4122-4128.
21. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES & Wang X (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91: 479-489.
22. Martin SJ & Green DR (1995). Protease activation during apoptosis: death by a thousand cuts? Cell, 82: 349-352.
23. Rudel T & Bokoch GM (1997). Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science, 276: 1571-1574.
24. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, Kirschner MW, Koths K, Kwiatkowski DJ & Williams LT (1997). Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science, 278: 294-298.
25. Li H, Zhu H, Xu CJ & Yuan J (1998). Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell, 94: 491-501.
26. Liu X, Li P, Widlak P, Zou H, Luo X, Garrard WT & Wang X (1998). The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. Proceedings of the National Academy of Sciences, USA, 95: 8461-8466.
27. Brunet CL, Gunby RH, Benson RSP, Hickman JA, Watson AJM & Brady G (1998). Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers. Cell Death and Differentiation, 5: 107-115.
28. Amarante-Mendes GP, Finucane DM, Martin SJ, Cotter TG, Salvesen GS & Green DR (1998). Anti-apoptotic oncogenes prevent caspase-dependent and -independent commitment for cell death. Cell Death and Differentiation, 5: 298-306.
29. McCarthy NJ, Whyte MKB, Gilbert CS & Evan GI (1997). Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. Journal of Cell Biology, 136: 215-227.
30. Xiang J, Chao DT & Korsmeyer SJ (1996). BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proceedings of the National Academy of Sciences, USA, 93: 14559-14563.
31. Green D & Kroemer G (1998). The central executioners of apoptosis: caspases or mitochondria? Trends in Cell Biology, 8: 267-271.
32. Green DR & Reed JC (1998). Mitochondria and apoptosis. Science, 281: 1309-1312.
33. Reed JC (1997). Double identity for proteins of the Bcl-2 family. Nature, 387: 773-776.
34. Pan G, O'Rourke K & Dixit VM (1998). Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. Journal of Biological Chemistry, 273: 5841-5845.
35. Mignotte B & Vayssiere JL (1998). Mitochondria and apoptosis. European Journal of Biochemistry, 252: 1-15.
36. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP & Wang X (1997). Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science, 275: 1129-1132.
37. Kluck RM, Martin SJ, Hoffman BM, Zhou JS, Green DR & Newmeyer DD (1997). Cytochrome c activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. EMBO Journal, 16: 4639-4649.
38. Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geuskens M & Kroemer G (1996). Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. Journal of Experimental Medicine, 184: 1331-1341.
39. Adams JM & Cory S (1998). The Bcl-2 protein family: arbiters of cell survival. Science, 281: 1322-1326.
40. Finucane DM, Bossy-Wetzel E, Waterhouse NJ, Cotter TG & Green DR (1999). Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. Journal of Biological Chemistry, 274: 2225-2233.
41. Luo X, Budihardjo I, Zou H, Slaughter C & Wang X (1998). Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell, 94: 481-490.
42. Ashkenazi A & Dixit VM (1998). Death receptors: signaling and modulation. Science, 281: 1305-1308.
43. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS & Dixit VM (1998). An induced proximity model for caspase-8 activation. Journal of Biological Chemistry, 273: 2926-2930.
44. Boldin MP, Goncharov TM, Goltsev YV & Wallach D (1996). Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell, 85: 803-815.
45. Hsu H, Huang J, Shu HB, Baichwal V & Goeddel DV (1996). TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity, 4: 387-396.
46. Duan H & Dixit VM (1997). RAIDD is a new 'death' adaptor molecule. Nature, 385: 86-89.
47. Hofmann K, Bucher P & Tschopp J (1997). The CARD domain: a new apoptotic signalling motif. Trends in Biochemical Sciences, 22: 155-156.
48. Chou JJ, Matsuo H, Duan H & Wagner G (1998). Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell, 94: 171-180.
49. Yeh WC, Pompa JL, McCurrach ME, Shu HB, Elia AJ, Shahinian A, Ng M, Wakeham A, Khoo W, Mitchell K, El Deiry WS, Lowe SW, Goeddel DV & Mak TW (1998). FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science, 279: 1954-1958.
50. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P & Ashkenazi A (1997). Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science, 277: 818-821.
51. Marsters SA, Sheridan JP, Pitti RM, Huang A, Skubatch M, Baldwin D, Yuan J, Gurney A, Goddard AD, Godowski P & Ashkenazi A (1997). A novel receptor for Apo2L/TRAIL contains a truncated death domain. Current Biology, 7: 1003-1006.
52. Medema JP, Scaffidi C, Krammer PH & Peter ME (1998). Bcl-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex. Journal of Biological Chemistry, 273: 3388-3393.
53. Srinivasan A, Li F, Wong A, Kodandapani L, Smidt Jr R, Krebs JF, Fritz LC, Wu JC & Tomaselli KJ (1998). Bcl-xL functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells. Journal of Biological Chemistry, 273: 4523-4529.
54. Kuwana T, Smith JJ, Muzio M, Dixit V, Newmeyer DD & Kornbluth S (1998). Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. Journal of Biological Chemistry, 273: 16589-16594.